Utama › Aterosklerosis › Minnesota
Kajian klinikal Aterosklerosis di Minnesota
6 kajian untuk Aterosklerosis sedang mencari peserta di lokasi di Minnesota.
Bandar di Minnesota
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- University of Minnesota, Minneapolis
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07448038Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Fairview Health Services M Health Fairview St Johns Hospital, Maplewood
- Minneapolis Heart Institute Foundation, Minneapolis
Mengambil pesertaFasa 3
Umur 45 hingga 99 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07037433Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- DCR Edina, Minneapolis
- Minneapolis VA Health Care System, Minneapolis
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Duluth
- Research Site, Minneapolis
- Research Site, Minneapolis
- dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT07000357Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?
- Allina Health, Minneapolis
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jul 2026 · NCT06471036Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Dis 2025 · NCT02915198Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.